Status:
UNKNOWN
Retinal Thrombosis and Atherosclerosis
Lead Sponsor:
University of Roma La Sapienza
Collaborating Sponsors:
University of Florence
Conditions:
Retinal Vein Occlusion
Eligibility:
All Genders
18+ years
Brief Summary
The retinal vein occlusion (RVO) is the second most common retinal disease after diabetic retinopathy, and is a common cause of unilateral visual loss. The risk factors that predispose to RVO are many...
Detailed Description
The retinal vein occlusion (RVO) is the second most common retinal disease after diabetic retinopathy, and is a common cause of unilateral visual loss. The occlusion of a branch of the central retinal...
Eligibility Criteria
Inclusion
- Clinical Suspicion of Retinal Vein Occlusion
- Written Informed Consent
Exclusion
- Pregnancy
- Short Life Expectancy
Key Trial Info
Start Date :
September 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT02257333
Start Date
September 1 2015
End Date
September 1 2020
Last Update
December 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sapienza University of Rome - Policlinico Umberto I Roma
Rome, I, Italy